Conjupri 5 MG (equivalent to levamlodipine maleate 6.4 MG) Oral Tablet
- RxCUI
- 2377373
- RxNorm name
- Conjupri 5 MG (equivalent to levamlodipine maleate 6.4 MG) Oral Tablet
- Display name
- Conjupri 5 MG (equivalent to levamlodipine maleate 6.4 MG) Oral Tablet
- Full name
- Conjupri 5 MG (equivalent to levamlodipine maleate 6.4 MG) Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Conjupri | LEVAMLODIPINE | CSPC Ouyi Pharmaceutical Co. Ltd | c3cca66e-348a-43e8-8f96-e995104dae3d | 2024-12-11 | Warnings, Adverse reactions | 2377373 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c3cca66e-348a-43e8-8f96-e995104dae3d | levamlodipine 5 MG Oral Tablet [Conjupri] | SBD | 6 | These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019 | 20241211 |
| c3cca66e-348a-43e8-8f96-e995104dae3d | CONJUPRI 5 MG Oral Tablet | PSN | 6 | These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019 | 20241211 |
| c3cca66e-348a-43e8-8f96-e995104dae3d | Conjupri 5 MG Oral Tablet | SY | 6 | These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019 | 20241211 |
| c3cca66e-348a-43e8-8f96-e995104dae3d | Conjupri 5 MG (equivalent to levamlodipine maleate 6.4 MG) Oral Tablet | SY | 6 | These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019 | 20241211 |
| f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4 | levamlodipine 5 MG Oral Tablet [Conjupri] | SBD | 2 | These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019 | 20220503 |
| f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4 | Conjupri 5 MG Oral Tablet | SY | 2 | These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019 | 20220503 |
| f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4 | Conjupri 5 MG (equivalent to levamlodipine maleate 6.4 MG) Oral Tablet | SY | 2 | These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019 | 20220503 |
| f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4 | CONJUPRI 5 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019 | 20220503 |